Intravenous AAV9-ATP7A plus subcutaneous copper histidinate optimizes outcomes in a lethal Menkes disease mouse model | Science Advances
Intravenous AAV plus subcutaneous CuHis represents a highly effective treatment for a lethal Menkes disease mouse model.
